Published in TB and Outbreaks Week, March 26th, 2002
An effective and economical vaccine for invasive infections with Streptococcus pneumoniae, the most common cause of pneumonia, has been available since 1983, noted lead researcher Susan Ray, MD, from the Emory University School of Medicine. Yet vaccination rates remain low, especially among nonwhite minorities and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.